Cargando…
The Potential of Zebrafish as a Model Organism for Improving the Translation of Genetic Anticancer Nanomedicines
In the last few decades, the field of nanomedicine applied to cancer has revolutionized cancer treatment: several nanoformulations have already reached the market and are routinely being used in the clinical practice. In the case of genetic nanomedicines, i.e., designed to deliver gene therapies to...
Autores principales: | C, Gutiérrez-Lovera, AJ, Vázquez-Ríos, J, Guerra-Varela, L, Sánchez, M, de la Fuente |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5748667/ https://www.ncbi.nlm.nih.gov/pubmed/29182542 http://dx.doi.org/10.3390/genes8120349 |
Ejemplares similares
-
Zebrafish as a Model for Anticancer Nanomedicine Studies
por: Al-Thani, Hissa F., et al.
Publicado: (2021) -
Anticancer Nanotherapeutics in Clinical Trials: The Work behind Clinical Translation of Nanomedicine
por: Parodi, Alessandro, et al.
Publicado: (2022) -
Edelfosine nanoemulsions inhibit tumor growth of triple negative breast cancer in zebrafish xenograft model
por: Saraiva, Sofia M., et al.
Publicado: (2021) -
The Potential of Nanomedicine to Unlock the Limitless Applications of mRNA
por: Taina-González, Laura, et al.
Publicado: (2022) -
Past, Present, and Future of Anticancer Nanomedicine
por: Kim, Kyungeun, et al.
Publicado: (2020)